3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinosarcoma
2
Brain Neoplasms
2
Wilms Tumor
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Intraductal Neoplasms
1
Ovarian Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Barrett Esophagus
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Adenoma, Islet Cell
1
Interventions
X-Rays
1
Omeprazole
1
Melatonin
1
Esomeprazole
1
Endoscopy, Digestive System
1
Endoscopy
1
Blood Specimen Collection
1
Biopsy
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Barrett Esophagus
×
X-Rays
×
Clear all
NCT01209013
2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3
Withdrawn